Per Gjorstrup

Co-Founder at Resolvyx Pharmaceuticals, Inc.

Per Gjorstrup

Per Gjorstrup

Co-Founder at Resolvyx Pharmaceuticals, Inc.

Overview
Career Highlights

Resolvyx Pharmaceuticals, Inc.

RelSci Relationships

298

Relationships
RelSci Relationships are individuals Per Gjorstrup likely has professional access to. A relationship does not necessarily indicate a personal connection.

Adjunct Professor, Department of Molecular & Cell Biology at Boston University - Henry M. Goldman School of Dental Medicine

Relationship likelihood: Average

Director at Psychogenics, Inc.

Relationship likelihood: Average

Co-Founder at Resolvyx Pharmaceuticals, Inc.

Relationship likelihood: Average

Former Pharmaceutical Director at Biovitrum AB

Relationship likelihood: Average

Executive Vice President of Research & Development at Miragen Therapeutics, Inc.

Relationship likelihood: Average

Chief Financial & Accounting Officer at Axovant Sciences Ltd.

Relationship likelihood: Average

Chief Operating Officer at Warp Drive Bio, Inc.

Relationship likelihood: Average

Founder at TCR2 Therapeutics, Inc.

Relationship likelihood: Average

Former Chief Scientific Officer & Head-R&D at Orexo AB

Relationship likelihood: Average

Deputy Director at Reabyran AB

Relationship likelihood: Average

In The News
Paths to Per Gjorstrup
Potential Connections via
Relationship Science
You
Per Gjorstrup
Co-Founder at Resolvyx Pharmaceuticals, Inc.
Education

The University is ranked as one of the top 100 in the world. They tackle complex problems and global challenges and work to ensure that knowledge and innovations benefit society. They provide education and research in engineering, science, law, social sciences, economics and management, medicine, humanities, theology, fine art, music and drama. Their 47 700 students and 7 500 employees are based at their campuses in Lund, Malm and Helsingborg. The University has a turnover of around SEK 7 475 million (EUR 844 million), of which two thirds is in research and one third in education. They are an international university with global recruitment. They cooperate with 680 partner universities in over 50 countries and are the only Swedish university to be a member of the strong international networks LERU (the League of European Research Universities) and Universitas 21. Two major facilities for materials research are currently under construction in Lund: the MAX IV Laboratory, which will be a world-leading synchrotron radiation laboratory and ESS, a European facility that will be home to the world's most powerful neutron source. These will be of decisive importance for materials and life sciences and for industrial development. In Lund, Medicon Village has also been established and will offer a unique environment for life sciences; integrating research, innovation and enterprise creates the conditions for improved health and quality of life.

Career History
Co-Founder
2005 - Prior

Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in 2005 and is headquartered in Cambridge, MA.

Chief Medical Officer
Prior

Micromet AG developed, manufactured and marketed novel antibody derived therapeutics for the treatment and control of cancer, inflammatory and autoimmune diseases. It's goal was to commercialize products in these indication areas that have significant unmet medical needs. Founded in 1993, the company was headquartered in Munich, Germany.

Head-Immunotherapeutics
Prior
Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1 - $999
2014

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

Transactions
Details Hidden

Resolvyx Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Resolvyx Pharmaceuticals, Inc. raised money in a private placement transaction

Investments
Details Hidden

Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in 2005 and is headquartered in Cambridge, MA.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Per Gjorstrup. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Per Gjorstrup's profile does not indicate a business or promotional relationship of any kind between RelSci and Per Gjorstrup.